VIRGINIA RETIREMENT SYSTEMS ET Al decreased its holdings in shares of Centene Corporation (NYSE:CNC – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 675,000 shares of the company’s stock after selling 70,600 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al owned 0.14% of Centene worth $27,776,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of Centene by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 56,978,753 shares of the company’s stock valued at $2,344,676,000 after buying an additional 190,334 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Centene by 76.6% during the third quarter. AQR Capital Management LLC now owns 14,654,834 shares of the company’s stock valued at $522,885,000 after buying an additional 6,356,152 shares during the last quarter. Deerfield Management Company L.P. grew its stake in shares of Centene by 184.0% during the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock valued at $322,761,000 after buying an additional 5,860,630 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Centene by 32.0% during the third quarter. Arrowstreet Capital Limited Partnership now owns 8,716,056 shares of the company’s stock valued at $310,989,000 after buying an additional 2,111,674 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its stake in shares of Centene by 34.8% during the third quarter. Ameriprise Financial Inc. now owns 7,290,041 shares of the company’s stock valued at $260,078,000 after buying an additional 1,881,041 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Stock Down 1.0%
NYSE:CNC opened at $58.71 on Thursday. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $62.21. The company’s 50-day simple moving average is $40.70 and its 200-day simple moving average is $40.51. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The stock has a market capitalization of $28.99 billion, a P/E ratio of -4.47, a P/E/G ratio of 1.15 and a beta of 1.06.
Analyst Ratings Changes
Several research analysts recently issued reports on CNC shares. Truist Financial increased their price objective on Centene from $49.00 to $58.00 and gave the stock a “buy” rating in a research note on Wednesday, April 29th. Sanford C. Bernstein increased their price objective on Centene from $48.00 to $68.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 5th. Argus upgraded Centene to a “hold” rating in a report on Monday, February 9th. Wall Street Zen upgraded shares of Centene from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Raymond James Financial set a $60.00 price target on shares of Centene in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $53.82.
Read Our Latest Stock Report on CNC
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Articles
- Five stocks we like better than Centene
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
